Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation
Vittorio Rosti, Laura Villani, Roberta Riboni, et al.
Blood (2012) Vol. 121, Iss. 2, pp. 360-368
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

Myeloproliferative neoplasms and thrombosis
Tiziano Barbui, Guido Finazzi, Anna Falanga
Blood (2013) Vol. 122, Iss. 13, pp. 2176-2184
Open Access | Times Cited: 374
Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation
Florian Perner, Caroline Perner, Thomas Ernst, et al.
Cells (2019) Vol. 8, Iss. 8, pp. 854-854
Open Access | Times Cited: 188
Cardiovascular Risk in Philadelphia-Negative Myeloproliferative Neoplasms: Mechanisms and Implications—A Narrative Review
Samuel Bogdan Todor, Cristian Ichim, Adrian Boicean, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8407-8423
Open Access | Times Cited: 19
Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis
Virginia Hernández‐Gea, Andrea De Gottardi, Frank W.G. Leebeek, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 1, pp. 175-199
Open Access | Times Cited: 106
Vascular endothelial cell expression of JAK2V617F is sufficient to promote a pro-thrombotic state due to increased P-selectin expression
Alexandre Guy, Virginie Gourdou-Latyszenok, Nicolas Le Lay, et al.
Haematologica (2018) Vol. 104, Iss. 1, pp. 70-81
Open Access | Times Cited: 101
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis
Paola Guglielmelli, Giuseppe Gaetano Loscocco, Carmela Mannarelli, et al.
Blood Cancer Journal (2021) Vol. 11, Iss. 12
Open Access | Times Cited: 80
JAK-STAT inhibition reduces endothelial prothrombotic activation and leukocyte–endothelial proadhesive interactions
Joan D. Beckman, Angelica DaSilva, Elena L. Aronovich, et al.
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 5, pp. 1366-1380
Open Access | Times Cited: 27
JAK2V 617 F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms
S. Leah Etheridge, Michelle E. Roh, Megan E. Cosgrove, et al.
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 6, pp. 2295-2300
Open Access | Times Cited: 89
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment
Silvia Betti, Elena Rossi, Valerio De Stefano, et al.
Thrombosis and Haemostasis (2015) Vol. 115, Iss. 02, pp. 240-249
Closed Access | Times Cited: 78
Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients
Nicola Polverelli, Massimo Breccia, Giulia Benevolo, et al.
American Journal of Hematology (2016) Vol. 92, Iss. 1, pp. 37-41
Open Access | Times Cited: 75
Endothelial Cells Harbouring the JAK2V617F Mutation Display Pro-Adherent and Pro-Thrombotic Features
Anna Guadall, Élodie Lesteven, Gil Letort, et al.
Thrombosis and Haemostasis (2018) Vol. 118, Iss. 09, pp. 1586-1599
Closed Access | Times Cited: 73
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms
Elena Tenedini, Isabella Bernardis, Valentina Artusi, et al.
Leukemia (2013) Vol. 28, Iss. 5, pp. 1052-1059
Open Access | Times Cited: 72
Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases
Valerio De Stefano, Elena Rossi, Alessandra Carobbio, et al.
Blood Cancer Journal (2018) Vol. 8, Iss. 11
Open Access | Times Cited: 69
Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.)
Stephan Kreher, Sebastian Ochsenreither, Ralf Ulrich Trappe, et al.
Annals of Hematology (2014) Vol. 93, Iss. 12, pp. 1953-1963
Closed Access | Times Cited: 67
Bone marrow fibrosis in primary myelofibrosis: pathogenic mechanisms and the role of TGF-β.
Archana M. Agarwal, Kerry Morrone, Matthias Bartenstein, et al.
PubMed (2016) Vol. 3, pp. 5-5
Closed Access | Times Cited: 63
Role of inflammation in the biology of myeloproliferative neoplasms
Steffen Koschmieder, Nicolas Chatain
Blood Reviews (2020) Vol. 42, pp. 100711-100711
Closed Access | Times Cited: 61
Current management strategies for polycythemia vera and essential thrombocythemia
Paola Guglielmelli, Alessandro M. Vannucchi
Blood Reviews (2020) Vol. 42, pp. 100714-100714
Open Access | Times Cited: 53
Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm
Johanne Poisson, Marion Tanguy, Hortense Davy, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 5, pp. 2630-2643
Open Access | Times Cited: 52
Laser capture microdissection for biomedical research: towards high-throughput, multi-omics, and single-cell resolution
Wenbo Guo, Yining Hu, Jingyang Qian, et al.
Journal of genetics and genomics/Journal of Genetics and Genomics (2023) Vol. 50, Iss. 9, pp. 641-651
Closed Access | Times Cited: 23
Splanchnic vein thrombosis in myeloproliferative neoplasms
Mallika Sekhar, Kathryn McVinnie, Andrew K. Burroughs
British Journal of Haematology (2013) Vol. 162, Iss. 6, pp. 730-747
Open Access | Times Cited: 71
Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms
Cecilia P. Marín Oyarzún, Paula G. Heller
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 53
Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease
Joan How, Amy Zhou, Stephen T. Oh
Therapeutic Advances in Hematology (2016) Vol. 8, Iss. 3, pp. 107-118
Open Access | Times Cited: 51
Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights
Erika Morsia, Elena Torre, Francesco Martini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1524-1524
Open Access | Times Cited: 5
Dysregulation of VEGF-induced proangiogenic Ca2+ oscillations in primary myelofibrosis-derived endothelial colony-forming cells
Silvia Dragoni, Marta Reforgiato, Estella Zuccolo, et al.
Experimental Hematology (2015) Vol. 43, Iss. 12, pp. 1019-1030.e3
Open Access | Times Cited: 49
The role of the extracellular matrix in primary myelofibrosis
Orly Leiva, S K Ng, Shlok V. Chitalia, et al.
Blood Cancer Journal (2017) Vol. 7, Iss. 2, pp. e525-e525
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top